Type 2 diabetes mellitus (DM) has reached pandemic proportions and effective prevention
strategies are wanted. Its onset is accompanied by cellular distress, the nuclear factor …

The incidence of both type 1 and type 2 diabetes is increasing globally, most likely
explained by environmental changes, such as changing exposures to foods, viruses, and …

The world is facing an epidemic rise in diabetes mellitus (DM) incidence, which is
challenging health funders, health systems, clinicians, and patients to understand and …

Immunologic and inflammatory processes are involved in the pathogenesis of acute
coronary syndrome (ACS) and type 2 diabetes mellitus (DM2). Human leukocyte antigen‐G …

Objectives Type 2 diabetes mellitus (DM2) is usually accompanied by various comorbidities
that can increase the cost of treatment. We are not aware of studies that have determined the …

Background Cardiomyopathy and distal symmetrical polyneuropathy (DSPN), including
sensory and autonomic dysfunction, often co-occur in diabetic mellitus (DM) patients …

The International Diabetes Federation estimated that 5.1 million people aged between 20
and 79 years died from diabetes in 2013, accounting for 8.4% of global all-cause mortality …

Objective: Statins are used to lower total cholesterol (TC) and low-density lipoprotein
cholesterol (LDL-C) levels among patients with type 1 (T1DM) and type 2 diabetes mellitus …

We tested whether short-term, low-dose treatment with the fluvastatin and valsartan
combination could improve impaired arterial wall characteristics in type 1 diabetes mellitus …

Aim: To compare healthcare resource utilization and costs according to smoking status in
patients with type 2 diabetes in clinical practice. Methods: A retrospective cohort nested case …